Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient.

about

Glutathione S-conjugates as prodrugs to target drug-resistant tumors.The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.

P2860

Q34024771-1956E68C-F04B-4A38-845A-1193FB8B5B49 Q34802502-1FFA5AD9-2C76-46E2-9063-0737F70756AF

P2860

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient.

Item

http://www.wikidata.org/entity/Q41875544

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient.

@en

type

Item

label

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient.

@en

prefLabel

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient.

@en

P1476

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient.

@en

P2093

Craig T Jordan

http://www.w3.org/2001/XMLSchema#string

Eftihia Cocolakis

http://www.w3.org/2001/XMLSchema#string

Eric Paquet

http://www.w3.org/2001/XMLSchema#string

Josée Hébert

http://www.w3.org/2001/XMLSchema#string

Kevin P Callahan

http://www.w3.org/2001/XMLSchema#string

Koren K Mann

http://www.w3.org/2001/XMLSchema#string

Lu Yao

http://www.w3.org/2001/XMLSchema#string

Nathalie Johnson

http://www.w3.org/2001/XMLSchema#string

Nicolas Garnier

http://www.w3.org/2001/XMLSchema#string

Robert A Morgan

http://www.w3.org/2001/XMLSchema#string

P2860

Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression

The role of EVI1 in normal and leukemic cells

Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide

A simple fluorescence method for surface antigen phenotyping of lymphocytes undergoing DNA fragmentation.

Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia

Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.

The interleukin-8 pathway in cancer.

Darinaparsin: a novel organic arsenical with promising anticancer activity.

Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line.

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2013.00009

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235621651

http://www.w3.org/2001/XMLSchema#string

P698

23408639

http://www.w3.org/2001/XMLSchema#string

P932

3570070

http://www.w3.org/2001/XMLSchema#string

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient.

about

P2860

P2860

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932